The Irish Times Business Person of the Month: Matt Cooper
Inflazome sells to Swiss pharma giant Roche for an initial €380 million
Tue, Apr 13, 2021, 02:06
The spark behind Inflazome came when Australian chemist Matt Cooper met Irish immunologist Luke O’Neill at a medical conference. The two men brainstormed the role of inflammasomes - part of the body’s immune system - in a host of serious chronic diseases when they spiral out of control.
Eight years later - and four years after the two men set up the company in Dublin - Inflazome was sold to Swiss pharma giant Roche for an initial €380 million.